PropertyValue
?:abstract
  • Abstract Identification of risk factors for contracting and developing serious illness following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is of paramount interest. Here, we performed a retrospective cohort analysis of all Danish individuals tested for SARS-CoV-2 between 27 February 2020 and 30 July 2020, with a known ABO and RhD blood group, to determine the influence of common blood groups on virus susceptibility. Distribution of blood groups was compared with data from nontested individuals. Participants (29% of whom were male) included 473 654 individuals tested for SARS-CoV-2 using real-time polymerase chain reaction (7422 positive and 466 232 negative) and 2 204 742 nontested individuals, accounting for ∼38% of the total Danish population. Hospitalization and death from COVID-19, age, cardiovascular comorbidities, and job status were also collected for confirmed infected cases. ABO blood groups varied significantly between patients and the reference group, with only 38.41% (95% confidence interval [CI], 37.30-39.50) of the patients belonging to blood group O compared with 41.70% (95% CI, 41.60-41.80) in the controls, corresponding to a relative risk of 0.87 (95% CI, 0.83-0.91) for acquiring COVID-19. This study identifies ABO blood group as a risk factor for SARS-CoV-2 infection but not for hospitalization or death from COVID-19.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1182/bloodadvances.2020002657
?:journal
  • Blood_Advances
?:license
  • els-covid
?:pdf_json_files
  • document_parses/pdf_json/4e0ba83500b188c612b4721601e0042238e1f714.json; document_parses/pdf_json/53a5f9d081e2ee9567b6ca5e0858de01c0afe17c.json
?:pmcid
?:pmid
?:pmid
  • 33057631.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Elsevier; Medline; PMC
?:title
  • Reduced prevalence of SARS-CoV-2 infection in ABO blood group O
?:type
?:year
  • 2020-10-27

Metadata

Anon_0  
expand all